Cargando…

The insulin and IGF signaling pathway sustains breast cancer stem cells by IRS2/PI3K-mediated regulation of MYC

Despite the strong association of the insulin/insulin-like growth factor (IGF) signaling (IIS) pathway with tumor initiation, recurrence, and metastasis, the mechanism by which this pathway regulates cancer progression is not well understood. Here, we report that IIS supports breast cancer stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ji-Sun, Lero, Michael W., Mercado-Matos, Jose, Zhu, Sha, Jo, Minjeong, Tocheny, Claire E., Morgan, Jennifer S., Shaw, Leslie M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793643/ https://www.ncbi.nlm.nih.gov/pubmed/36476848 http://dx.doi.org/10.1016/j.celrep.2022.111759

Ejemplares similares

The Insulin-like Growth Factor Signaling Pathway in Breast Cancer: An Elusive Therapeutic Target
por: Lee, Ji-Sun, et al.
Publicado: (2022)

Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)
por: Piper, Andrew J., et al.
Publicado: (2019)

Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis
por: Beneit, N., et al.
Publicado: (2016)

IRS-1 acts as an endocytic regulator of IGF-I receptor to facilitate sustained IGF signaling
por: Yoneyama, Yosuke, et al.
Publicado: (2018)

Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs
por: Eschweiler, Simon, et al.
Publicado: (2022)

Immunolocalization of insulin-like growth factor-I (IGF-I) and its receptors (IGF-IR) in the equine epididymis
por: YOON, Minjung, et al.
Publicado: (2014)

Triterpenoid Saponins from Stauntonia chinensis Ameliorate Insulin Resistance via the AMP-Activated Protein Kinase and IR/IRS-1/PI3K/Akt Pathways in Insulin-Resistant HepG2 Cells
por: Hu, Xin, et al.
Publicado: (2014)

The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
por: Harrington, Laura S., et al.
Publicado: (2004)

IGF-IR signaling in epithelial to mesenchymal transition and targeting IGF-IR therapy: overview and new insights
por: Li, Heming, et al.
Publicado: (2017)

Novel cross-talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses
por: Malaguarnera, Roberta, et al.
Publicado: (2015)

VAPB-mediated ER-targeting stabilizes IRS-1 signalosomes to regulate insulin/IGF signaling
por: Gao, Xiu Kui, et al.
Publicado: (2023)

EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia
por: Kosalai, Subazini Thankaswamy, et al.
Publicado: (2019)

Interaction between IGF-IR and ER Induced by E2 and IGF-I
por: Yu, Zhenghong, et al.
Publicado: (2013)

Sensing and Integration of Erk and PI3K Signals by Myc
por: Lee, Tae, et al.
Publicado: (2008)

Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR–IGF1R hybrid receptor modulators
por: Turvey, Samuel J., et al.
Publicado: (2022)

LncIRS1 controls muscle atrophy via sponging miR‐15 family to activate IGF1‐PI3K/AKT pathway
por: Li, Zhenhui, et al.
Publicado: (2019)

The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
por: Tzanakakis, George N., et al.
Publicado: (2021)

The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia
por: Yang, Liying, et al.
Publicado: (2018)

MicroRNA-506 modulates insulin resistance in human adipocytes by targeting S6K1 and altering the IRS1/PI3K/AKT insulin signaling pathway
por: Zhong, Feng-Yu, et al.
Publicado: (2021)

IGF-IR determines the fates of BCR/ABL leukemia
por: Xie, Jingjing, et al.
Publicado: (2015)

IGF-IR Targeted Therapy: Past, Present and Future
por: Janssen, Joseph A. M. J. L., et al.
Publicado: (2014)

Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease
por: Andreucci, Michele, et al.
Publicado: (2022)

Carpachromene Ameliorates Insulin Resistance in HepG2 Cells via Modulating IR/IRS1/PI3k/Akt/GSK3/FoxO1 Pathway
por: Alaaeldin, Rania, et al.
Publicado: (2021)

The Chinese herbal medicine FTZ attenuates insulin resistance via IRS1 and PI3K in vitro and in rats with metabolic syndrome
por: Hu, Xuguang, et al.
Publicado: (2014)

Increased IRS2 mRNA Expression in SGA Neonates: PCR Analysis of Insulin/IGF Signaling in Cord Blood
por: Fujimoto, Masanobu, et al.
Publicado: (2017)

The novel IGF-IR/Akt–dependent anticancer activities of glucosamine
por: Song, Ki-Hoon, et al.
Publicado: (2014)

Cross-Talk between Adiponectin and IGF-IR in Breast Cancer
por: Mauro, Loredana, et al.
Publicado: (2015)

IGF-IR: a new prognostic biomarker for human glioblastoma
por: Maris, C, et al.
Publicado: (2015)

Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma
por: Berthold, Ruth, et al.
Publicado: (2022)

Data on the expression and insulin-stimulated phosphorylation of IRS-1 by miR-96 in L6-GLUT4myc myocytes
por: Yang, Won-Mo, et al.
Publicado: (2017)

Anticarcinogenic effect of quercetin by inhibition of insulin-like growth factor (IGF)-1 signaling in mouse skin cancer
por: Jung, Minjeong, et al.
Publicado: (2013)

IGF-IR Internalizes with Caveolin-1 and PTRF/Cavin in Hacat Cells
por: Salani, Barbara, et al.
Publicado: (2010)

IGF-IR Mediated Mammary Tumorigenesis Is Enhanced during Pubertal Development
por: Jones, Robert A., et al.
Publicado: (2014)

Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature
por: Franks, S E, et al.
Publicado: (2012)

Biglycan Interacts with Type I Insulin-like Receptor (IGF-IR) Signaling Pathway to Regulate Osteosarcoma Cell Growth and Response to Chemotherapy
por: Giatagana, Eirini-Maria, et al.
Publicado: (2022)

Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer
por: Elbaz, Mohamad, et al.
Publicado: (2016)

Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer
por: Roche, Sandra, et al.
Publicado: (2023)

Understanding the Mechanism of Insulin and Insulin-Like Growth Factor (IGF) Receptor Activation by IGF-II
por: Alvino, Clair L., et al.
Publicado: (2011)

The complete salmonid IGF-IR gene repertoire and its transcriptional response to disease
por: Alzaid, Abdullah, et al.
Publicado: (2016)

New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations †
por: Janssen, Joseph A.M.J.L.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_90aa53o3p7f6l67svm1ker8m58